Go Back

Literature in Oncology: Lung

Møller DS, Khalil AA, Knap MM, Hoffmann L.

Adaptive radiotherapy of lung cancer patients with pleural effusion or atelectasis.

Radiother Oncol. 2014 Mar;110(3):517-22.


Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Bertagna F, Prior JO, Ceriani L, Giovanella L.

Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.

Acad Radiol. 2014 Jan;21(1):11-20


Sim YT, Goh YG, Dempsey MF, Han S, Poon FW.

PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.

Lung. 2013 Dec;191(6):625-32.


Schaefer A, Kim YJ, Kremp S, Mai S, Fleckenstein J, Bohnenberger H, Schäfers HJ, Kuhnigk JM, Bohle RM, Rübe C, Kirsch CM, Grgic A.

PET-based delineation of tumour volumes in lung cancer: comparison with pathological findings.

Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1233-44.


Hatt M, Cheze-le Rest C, van Baardwijk A, Lambin P, Pradier O, Visvikis D.

Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineation.

J Nucl Med. 2011 Nov;52(11):1690-7.


PDFFree pdf

Gerbaudo VH, Mamede M, Trotman-Dickenson B, Hatabu H, Sugarbaker DJ.

FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.

Eur J Nucl Med Mol Imaging. 2011 May;38(5):810-21.


Pommier P, Touboul E, Chabaud S, Dussart S, Le Pechoux C, Giammarile F, Carrie C.

Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: A prospective multicenter study.

AJR Am J Roentgenol. 2010 Aug;195(2):350-5.


Stahel RA, Weder W, Lievens Y, Felip E; ESMO Guidelines Working Group.

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2010 May;21 Suppl 5:v126-8.


Chee KG, Nguyen DV, Brown M, Gandara DR, Wun T, Lara PN Jr.

Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited.

Arch Intern Med. 2008 Jul 28;168(14):1541-9.


Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, Langen HJ, Bares R.

18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer.

Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):463-71.


Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL.

Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):709-19.


Song Y, Chan M, Burman C, Cann D.

Inter-modality variation in gross tumor volume delineation in 18FDG-PET guided IMRT treatment planning for lung cancer.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:3803-6.


Schillaci O.

Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.

Semin Nucl Med. 2006 Oct;36(4):275-85.